Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Moodys
Baxter
Colorcon
Mallinckrodt

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Naphazoline Hydrochloride And Pheniramine Maleate patents expire, and what generic alternatives are available?

Naphazoline Hydrochloride And Pheniramine Maleate is a drug marketed by Akorn Inc and Altaire Pharms Inc and is included in two NDAs.

The generic ingredient in NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.

Summary for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Drug patent expirations by year for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Recent Clinical Trials for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EMSPhase 3

See all NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE clinical trials

US Patents and Regulatory Information for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 202795-001 Jan 24, 2013 OTC No No   Start Trial   Start Trial   Start Trial
Altaire Pharms Inc NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 078208-001 Sep 27, 2010 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKinsey
Colorcon
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.